Carl Hull has been elected to the board of directors of the CHI-California Healthcare Institute, a non-profit public policy research organization that represents California academic institutions, biotechnology, medical device, diagnostics, and pharmaceutical firms.
Hull is currently president and CEO of Gen-Probe. Previously, he was vice president and general manager of the SDS/arrays business unit of Applied Biosystems. Prior to that, he held a number of positions, including that of CEO, with Applied Imaging. Hull holds a master's degree in business administration from the University of Chicago and a bachelor's degree in political science and international relations from Johns Hopkins University.